Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Operational performance of the 2023 World Heart Federation screening criteria for rheumatic heart disease in a high-risk, resource-limited population.

Open heart·2026
Same author

IdeaDistiller-AI Support for Idea Synthesis in Concept Mapping: Algorithm Development and Validation Study.

JMIR medical informatics·2026
Same author

Inspiring, shaping and sustaining an African research & development agenda.

Nature medicine·2026
Same authorSame journal

<i>Streptococcus Pyogenes</i> and Acute Rheumatic Fever: How Strong are the Links in the Chain?

Global heart·2026
Same author

Impact of Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease Over 5 Years.

Journal of the American Heart Association·2026
Same author

Early Implementation and Clinical Outcomes of an Integrated Rheumatic Heart Disease Screening and Treatment Program in Northern Uganda.

Circulation. Population health and outcomes·2026

Related Experiment Videos

Co-Developing Strategies for Patient Engagement in Decentralized Rheumatic Heart Disease Care: Lessons from Northern

Jafesi Pulle1,2,3, Lisa Vaughn4, Isaac Otim1,2

  • 1Rheumatic Heart Disease Research Collaborative, Kampala, Uganda.

Global Heart
|June 29, 2026
PubMed
Summary

Improving patient engagement in rheumatic heart disease (RHD) care in Uganda is crucial. A human-centered design approach co-developed strategies to overcome barriers like missed appointments and medicine stockouts in decentralized settings.

Keywords:
ADUNUUgandaco-designhuman-centered designrheumatic heart disease

Related Experiment Videos

Area of Science:

  • Public Health
  • Health Systems Strengthening
  • Cardiovascular Disease Prevention

Background:

  • Rheumatic heart disease (RHD) necessitates long-term antibiotic prophylaxis, posing challenges for patient adherence in low- and middle-income countries.
  • Sustained patient engagement is critical for preventing RHD progression but is often hindered by systemic and individual barriers.

Purpose of the Study:

  • To co-develop contextually relevant strategies for enhancing patient engagement in a decentralized RHD control program in Uganda.
  • To address key barriers identified by stakeholders within the Accelerating Delivery of Rheumatic Heart Disease Preventive Services in Uganda (ADUNU) program.

Main Methods:

  • A human-centered design (HCD) approach was employed, including Group Level Assessment sessions (n=43) and design focus groups (n=23).
  • Stakeholders identified and prioritized feasible strategies for improving care engagement within primary care settings.

Main Results:

  • Four strategic domains emerged: community integrated follow-up, enhanced patient education and counseling, improved provider capacity and service delivery, and strengthened medicine stock planning.
  • Co-developed strategies directly target missed appointments, limited RHD understanding, suboptimal provider-patient interactions, and medicine stockouts.

Conclusions:

  • The participatory HCD approach successfully generated contextually grounded strategies for decentralized RHD programs.
  • These co-developed strategies are poised for prospective testing to improve long-term patient engagement and RHD management.